13F Pro

SEC Form 4 reporting owner

Malik Fady Ibraham

Malik Fady Ibraham has filed 25 Form 4 transactions reported between December 2, 2025 and September 22, 2026, as EVP Research & Development of CYTOKINETICS INC and a reporting owner of ROCKET PHARMACEUTICALS, INC..

Name as filed: Malik Fady Ibraham

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$924K
3 lines
Companies
2
with Form 4 filings
Latest transaction
Sep 22, 2026
transaction date

Roles and reported holdings

  • CYTKCYTOKINETICS INC
    Dec 2, 2025 – Sep 22, 2026

    EVP Research & Development

    Held directly153,902 sh as of Mar 17, 2026 · Form 4

    24 months: $924K sold

  • RCKTROCKET PHARMACEUTICALS, INC.
    Jun 18, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 25 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 22, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Sep 8, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Aug 18, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Jul 21, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Jul 7, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Jun 23, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Jun 18, 2026RCKTGrant or awardCode A · direct64,860—Form 4
Jun 18, 2026RCKTGrant or awardCode A · direct22,862—Form 4
Jun 9, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
May 19, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
May 5, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Apr 21, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Apr 7, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct1,000$11K@ $10.60Form 4
Apr 7, 2026CYTKEVP Research & DevelopmentOption exerciseCode M · direct3,500$27K@ $7.80Form 4
Mar 17, 2026CYTKEVP Research & DevelopmentOpen-market saleCode S · direct4,397$273K@ $62.15Form 4
Mar 17, 2026CYTKEVP Research & DevelopmentOpen-market saleCode S · direct7,636$475K@ $62.15Form 4
Mar 15, 2026CYTKEVP Research & DevelopmentGrant or awardCode A · direct39,527—Form 4
Mar 15, 2026CYTKEVP Research & DevelopmentGrant or awardCode A · direct1,665—Form 4
Mar 15, 2026CYTKEVP Research & DevelopmentGrant or awardCode A · direct27,306—Form 4
Mar 9, 2026CYTKEVP Research & DevelopmentOpen-market saleCode S · direct2,907$177K@ $60.72Form 4
Dec 22, 2025CYTKEVP Research & DevelopmentShares withheld for tax or exercise priceCode F · direct1,016$64K@ $62.72Form 4
Dec 22, 2025CYTKEVP Research & DevelopmentGrant or awardCode A · direct2,000—Form 4
Dec 16, 2025CYTKEVP Research & DevelopmentOption exerciseCode M · direct2,200$23K@ $10.60Form 4
Dec 3, 2025CYTKEVP Research & DevelopmentShares withheld for tax or exercise priceCode F · direct2,058$134K@ $65.02Form 4
Dec 2, 2025CYTKEVP Research & DevelopmentOption exerciseCode M · direct2,200$23K@ $10.60Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.